Poland - Pharmaceutical products
For more information and to make a bid you will need to go to the third party website.
Details
Provided by
- Opportunity closing date
- 22 July 2020
- Opportunity publication date
- 16 June 2020
- Category
- 33600000: Ph
- Value of contract
- to be confirmed
- Your guide to exporting
Description
Supply of medicinal products, foodstuffs for special nutritional purposes and medical device. The medicinal products offered by the Contractors in this proceeding must meet the requirements arising from the Act of 6 September 2001. Pharmaceutical Law (consolidated text in Journal of Laws of 2019, item 499 as amended).The Contractor offering a product included in the list of reimbursed medicines must take into account the provisions of art. 9 of the Act of 12 May 2011 on reimbursement of medicines, foodstuffs for special nutritional purposes and medical devices (consolidated text in Journal of Laws of 2019, item 784 as amended).foodstuffs for special nutritional purposes and diet. The foodstuffs for medical purposes offered by the Contractors must be subject to the provisions of the Act on Food and Nutrition Safety (i.e. Journal of Laws 2017, item 149) and the Health Regulation of 16 September 2010 on foodstuffs for special nutritional purposes (i.e. Journal of Laws 2010, No. 180).
1 Varicella /Zoster immunoglobulins; * execution 6-8 hours 125 IU/5ml amp 152 Varicella /Zoster immunoglobulins; * execution 6-8 hours 500 IU./20ml amp 30 Amikacin 500mg/100ml bottle 1400 1 Amlodipine + PERYndopril 10mg amlodipine + 10mg peryndopril; tbl 1202 Amlodipine + PERYndopril 10mg amlodipine + 5mg peryndopril; tbl 4503 Ammlodipine + Peridopril 5mg amlodipine + 5mg peridopril; tbl 5404 Ammlodipine + Peridopril 5mg amlodipine + 10mg peridopril; tbl 2105 Trimethazidine 35mg, tbl 2105 Ammlodipine + 10mg peridopril; tbl 1202 Ammlodipine + Peridopril Modification.release tbl 14406 Indapamide + Perndopril 0.625mg indapamide + 2.5mg peryndopril tbl 3607 Indapamide + Perndopril 1.25mg indapamide + 5mg peryndopril tbl 360 Denosumab 60mg, solution for injection; 1 amp-string amp 5 1 Ketamine 50mg/ml (500mg/10ml), solution for injection amp 10002 Misoprostol 0,2mg; tbl 603 Trimebutin 4,8mg/ml (24mg/5ml); op a 250ml op a 250ml op 344 Diclofenac + Misoprostol 50mg diclofenac + 0,2mg Misoprostol tbl 48005 Anidulafungin 100mg; r-ru concentrate powder for infusion amp 206 Diltiazem 90mg; tbl 607 Methylprednisolone 40 mg; powder and dilution for solution for injection; 1op = 1 vial + 1 solution op 16128 Methylprednisolone 250 mg; powder and dilution for solution for injection; 1op = 1 vial + 1 solution op 1128 Methylprednisolone 500 mg; powder and dilution for solution for injection; 1op = 1 vial + 1 solution op 1129 Methylprednisolone 1000mg; powder and dilution for solution for injection; 1op = 1 vial + 1 solution op 35610 Voriconazole 200mg; powder and dilution. Solution for infusion amp 50011 Ceftazidim + avibactam 2g ceftazidim + 0.5g avibactam, solution for infusion amp 2012 Thygeocycline 50mg; powder and dilution for infusion amp 50011 Solution for infusion amp 20013 Meropene *Antibiotics in patients with a bacterium that is associated with or suspected of being associated with any of the infections listed below: bronchitis and pneumonia in the course of cystic fibrosis; complicated urinary tract infections; complicated abdominal infections; intra- and postnatal infections; complicated skin and soft tissue infections; Acute bacterial meningitis and chemical and physical persistence of infusion solution prepared with 0.9% sodium chloride solution when stored for 3 hours at up to 25oC or 24 hours when stored refrigerated (2-8oC) -information confirmed by the CHPL records; please refer to the following Solution for injection and infusion; 1000mg, one responsible entity required amp 15014 Meropene *Adjustment of patients with a bacterium that is associated with or suspected of being associated with any of the infections listed below: bronchitis and pneumonia in the course of cystic fibrosis; complicated urinary tract infections; complicated abdominal infections; intra- and postnatal infections; complicated skin and soft tissue infections; Acute bacterial meningitis and chemical and physical persistence of infusion solution prepared with 0.9% sodium chloride solution when stored for 3 hours at up to 25oC or 24 hours when stored refrigerated (2-8oC) -information confirmed by the CHPL records; please refer to the following Solution for injection and infusion; 500mg, one responsible entity required amp 150 1 Diazepam 2mg tbl 9602 Buprenorphine 35uh/h (20mg buprenorphine) pcs 1700 1 Thiamazoles 40mg/ml amp 202 Sulfadiazine 0,5g tabl. 300 Thiopental sodium 1 g vial. 150 1 morphine (morphine sulphate) 10mg/ml amp a 1ml, solution for injection amp 33802 morphine (morphine sulphate) 20mg/ml amp a 1ml, solution for injection amp 11003 morphine (morphine sulphate) 1mg/ml amp a 2ml, Solution for injection amp 10004 oxycodone (oxycodone hydrochloride) 5mg, tbl 1205 oxycodone (oxycodone hydrochloride) 20mg, tbl 1206 oxycodone (oxycodone hydrochloride) 40mg, tbl 1207 morphine (morphine sulphate) 30mg, tbl 1208 sufentanyl 50ug/ml, amp a 5ml amp 360 1 diazepam 2mg/ml (5mg/2.5ml) rectal micro infusion, infusion solution 1202 phenobarbital 15mg, tbl tbl 403 phenobarbital 100mg, tbl tbl 40 1 Adenosine 3mg/ml (6mg/2ml); Solution for injection amp 1682 sodium valproate + valproic acid 1 sachet contains 166.76mg of sodium valproate, 72.61mg of valproic acid; 1 op a 30s sachet 603 sodium valproate + valproic acid 1 sachet contains 333.33mg of sodium valproate, 145.14mg of valproic acid; 1 op a 30 sachets sachet 21604 Amiodarone 200mg, tbl tabl 27005 isosorbide mononitrate 20mg, tbl tabl 1206 isosorbide mononitrate 40mg, tbl tabl 1207 isosorbide mononitrate 100mg; tbl with lead release 1208 Sotalol 80mg; tbl with tabl 1440 1 Enoxaparin 20mg/0,2ml x 1 amp-spade syringe 2702 Enoxaparin 40mg/0,4ml x 1 amp-spade syringe 42203 Enoxaparin 100mg/ml x 1 amp-spade syringe 550 Theicoplanine 400mg; powder for solution for injection and infusion; 1op = 1 vial. + 1amp. 3Ml op 570 Sodium valproate 400 mg; powder for solution for injection; 1op - 1amp with powder + 1amp with 4 ml amp 600 .1 Humanum insulinum - two-phase isophane insulin suspension containing 25 % soluble insulin and 75 % crystalline protamine insulin.Obtained by recombination of DNA in E.coli cells. (After subcutaneous injection start of action in 30 to 60 min,peak activity in 2-4 hours. The duration of action is 12-19 h.) 100j/ml; 3ml insert 102 Humanum Insulinum obtained by recombination of DNA in E.coli strains contains insulin of moderately fast onset and long duration of action. (After subcutaneous injection, start of action within 60 min, peak action within 3-4 h.The duration of action is 11-20 hours.) 100j/ml; cartridge 3ml cartridge 103 Humanum-neutral insulin solution. Obtained by recombination of DNA in E.coli cells, it contains insulin with a rapid onset and a short duration of action. (After subcutaneous injection the beginning of action in 30min., peak of action 1-4h. The duration of action is 7-9 h) 100j/ml; 3ml insert 104 Insulin glargine 100j/ml; 3ml insert 205 Insulin glargine 300j/ml; insert 1,5ml for injector 20 Polystyrene sulfonate 15g powder contains 1,42g sodium ions in the form of sodium salt of sulfonated polystyrene resin 99,934 %; 1 op a 454g op 75 1 Spiramycin 1,5mln j.m.; tbl coat tabl 322 Spiramycin 3,0 million IU.tbl coat tabl 20 1 fluconazole 2mg/ml; RTU 50ml amp 12202 fluconazole 2mg/ml; RTU 200ml amp 6303 potassium chloride 150mg/ml; amp a 10ml amp 10004 potassium chloride 150mg/ml; amp a 20ml amp 231205 ondasetron 2mg/ml (8mg/4ml); amp a 4ml amp 39206 piperacillin + tazobactam 1 vial. Contains 2g piperacillin, 250mg tazobactam vial 1507 Cyclin + imipenem 1 vial. Contains 500mg imipenem + 500mg cyclinem vial 14608 Levofloxacin 500mg/100ml, r-ru for infusion amp 4190 Phosphomycin gran. for oral solution, dose 3g; 1op contains 1 sachet op 50 1 Aluminium acetate 1.0g, tabl. 4002 Amoxicillin 250mg/5ml; 60ml oral suspension op 203 Phenoxymehylpenicillin 1 500 000 IU; Tabletable 2884 Phenoxymehylpenicillin 1 000 000 IU; Tabletable 365 Phenoxymehylpenicillin 750 000 IU/5ml(60ml); Oral suspension op 206 Ketoprofen 100mg/2ml amp. 271607 Ketoprofen 100mg tabl.pl 74408 Diclofenac sodium 75mg/3ml; amp. 209 Diclofenac sodium 50mg; table top-coating 450010 Pantoprazoles 40mg; amp inj.fiol. 1323011 Ferrum 100 mg/5ml amp 1012 Ferric oxide polymaltose complex 100 mg/ml amp 5013 Filgrastim 30 million IU./0,5 ml amp-head 1014 Filgrastim 48 million IUU/0,5 ml amp-head 180 1 Pefloxacin 400mg; table 1002 Pefloxacin 400mg/5ml; amp a 5ml amp 200 Aciclovir 500mg; vial vial. 100 1 Amoxicillin +clavulanic acid 375mg; tabl. 2102 Metildigoxin 0.1 mg tbl 60 Epoietin alpha 10 000j.m./ml pre-filled syringe a 0.5ml amp-string 6 1 Amitriptyline 0.025 g tabl. 8402 Amitriptyline 0.01 g tabl. 13203 Cetirizine 0.01 g tabl. 48404 Clemastine 0.001 g tabl. 60605 Clotrimazole 0.1 g tabl. vag. 2766 Dexamethasone 0.001 g Table 18807 Digoxin 0.1 mg Table 30008 Digoxin 0.25 mg Table 3609 Etamsylate 0.25 g Table 528010 Ferrous sulphate 80 mg (Fe +2) Table A.V. 1248011 Furazidin 0.05 g Cable 1956012 Furosemide 0.04 g Cable 2406013 Nitrendypine 0.01 g Cable 450014 Nitrendypine 0.02 g Cable 66015 Perazine 0.025 g Cable 404016 Perazine 0.1 g Cable 57017 Prednisone 0.005 g Cable 140018 Propranolol 0.01 g Cable 150019 Propranolol 0.04 g Cable 150019 Propranolol 0.04 g Cable 50020 Pyridostigmine bromide 60 mg Tablet. 90021 Spironolactone 0.1 g Tablet. 200022 Spironolactone 0.025 g Tablet. 760023 Thiamazoles 0.005 g Tablet. 5600 Itopride 50 mg, tablets Tablet. 10000 1 Rapid Alcoholic acid 10mg/ml; amp a 10ml amp 7902 Rapid Alcoholic acid 5mg/ml; amp a 10ml amp 340 Ranitidine 50mg/5ml; amp. 480 1 Fludrocortisone 1mg/g (0.1 %), tube a 3g, eye ointment op 982 Fludrocortisone 1 tabl. contains 0,1mg fludrocortisone tbl 3603 Hydrocortison 20mg; tbl 1204 Lidocaine 20mg/g (2 %), tube a 30g op 3045 Lidocaine 20mg/g (2 %), tube a 30g + cannula op 506 Flumethasone - Salicylic acid 1g contains: 0,2mg flumethasone, 30mg salicylic acid; op a 15g op 107 Neomycin 5mg/g; eye ointment; op a 3g op 2368 Promazine 25mg; irritation pcs 2409 Rocuronium bromide 50mg/5ml; amp a 5ml amp 3010 Rocuronium bromide 100mg/10ml; amp a 10ml amp 14011 Suxamethonium 200mg; amp 165012 Sodium sulphatiazole salt 20mg/g; op a 400g op 4213 Ambroxol hydrochloride 0,015 g/2 ml amp 646014 Acyclovir 250mg amp 3200 Azithromycin 500mg; infusion solution powder amp 60 1 Cefuroxime 1500mg; infusion solution powder amp 173702 Cefuroxime 750mg; infusion solution powder amp 1670 Cefuroxime 50mg; powder for solution for injection amp 2280 1 Atracurium 10mg/ml; amp a 5ml; solution for injection or infusion amp 46602 Atracurium 10mg/ml; amp a 2,5ml; solution for injection or infusion amp 500 Calcio gluconato 10 ml (10 %), target import amp. 7200 1 Analogue Insulinum aspart - fast-acting, obtained by recombination of DNA in Saccharomyces cerevisiae (after subcutaneous injection, start of action after about 10-20 minutes,peak effect after 1- 3h .Effect time 3 - 5h); 100 IU/ml; 3 ml insert 18802 Insulinum humanum isophanum - prolonged effect time obtained by recombination of DNA in Saccharomyces cerevisiae (after subcutaneous injection start of effect after about 1.5h, peak effect between 4-12h. Activity time approx. 24h); 100 IU/ml; 3 ml insert 7703 Insulinum humanum, isophanum - a mixed two-phase, two-phase insert obtained by recombination of DNA in Saccharomyces cerevisiae, containing a combination of short-acting and prolonged insulin in the ratio 30/70, (after subcutaneous injection, start of action after approx. 0.5h, peak of action between 2 - 8h. Action time up to 24 h); 100 IU/ml; 3 ml cartridge; 3 ml cartridge 204 Insulinum insulinum aspart analogue - biphasic obtained by recombination of DNA in Saccharomyces cerevisiae containing 30 % soluble aspart insulin and 70 % crystallized aspart insulin with protamine, (after subcutaneous injection start of action after approx. 10-20 min,peak action 1-4h, duration of action up to 24h); 100 IU/ml; cartridge 3 ml cartridge 2405 Analogue-biphasic insulinum aspartate obtained by recombination of DNA in Saccharomyces cerevisiae containing 50 % soluble aspartate insulin and 50 % crystallised aspartate insulin with protamine (after subcutaneous injection start of action after approx. 10-20 min, peak action 1-4h. Action time 14 to 24h); 100 IU/ml; 3 ml cartridge 206 Analogue-long acting detemirum insulinum obtained by recombination of DNA in Saccharomyces cerevisiae. Actuation time exceeds 24 h .; 100 IU/ml; cartridge 3 ml cartridge 20 1 Betahistin 24mg, tbl 12002 Carbamazepine 200mg; tbl 2003 Carbamazepine 200mg; tbl 6004 Doxepine 10mg; tbl 1205 Haloperidol 1mg; tbl 41601 Levodopaeda + Benserazide 1 capsule contains: 50 mg levodopa + 12.5mg benserazid cap. 14006 Levodopa + Benserazid 100mg levodopa + 25mg benserazid; cap. 14007 Levodopa + Benserazid 100mg levodopa + 25mg benserazid; cap. 10008 Levodopa + Benserazid 200mg levodopa + 25mg benserazid; cap. 4009 Manserine 10mg; tbl 12010 Sertraline 50mg; tbl 300011 Sertraline 100mg; tbl 15012 Sulpiride 100mg; tbl 26413 Sulpiride 50mg; tbl 52813 Tolperyzone 150mg; tbl 6014 Quetiapin 25mg; tbl 14940 1 Budesonide 0.25mg/ml; amp a 2ml amp 227602 Butamirate 5mg/ml; op a 20ml; oral drops, solution op 83 Ambroxol 30mg; tbl 404 Bromhexine 8mg; Table tbl 56805 Flutazone (flutazone propionate) 125ug/inhalation dose; CFC-free inhalation aerosol, suspension op 106 Flutazone (flutazone propionate) 50ug/inhalation dose; CFC-free inhalation aerosol, suspension op 47 Flutazone (flutazone propionate) 250ug/Inhalation dose; CFC-free inhalation aerosol, suspension op 108 Flutazone (flutazone propionate) 1mg/ml (2mg/2ml); suspension op 108 For nebulization amp 1009 Xylmetasoline 1mg/ml; nasal drops, op a 10ml op 7410 Xylmetasoline 1mg/ml (0,1 %); nasal spray; op a 10ml op 106611 Salbutamol 100ug/Inhalation dose; CFC-free inhalation aerosol, suspension; 1 op a 200 doses = 20ml op 1812 Salbutamol 1mg/ml (0,1 %); nebulizer inhalation fluid; amp a 2,5ml amp 20013 Salbutamol 2mg/ml (0,2 %); Inhalation fluid from a nebulizer; amp a 2,5ml amp 744014 Salbutamol 0,5mg/ml; amp a 1ml; solution for injections amp 57015 Salbutamol 2mg; tbl 54016 Tiotropium 18ug/inhalation dose; Inhalation powder and inhaler cap 36017 Theophylline 100mg; tbl 90018 Theophylline 300mg; tbl 2000 1 Immunoglobulinum humanum anti-D 50 mcg/1 ml, 1 amp.teat. 50 mcg/1ml; amp. 1602 Immunoglobulinum humanum anti-D 150 mcg/1 ml, 1 amp. of teat. 150 mcg/1 ml; amp-intramuscular. Amp 250 1 Cefuroxime 50mg/ml (250mg/5ml); granules for oral use op 122 Cefuroxime 500mg; tbl 2720 potassium canrenoate 20mg/ml; amp a 10ml amp 180 Hioscin 20mg/ml; amp a 1ml amp 4510 1 Phenoterol + Ipratropium 1 dose: 50ug phenoterol + 20ug ipratropium; inhalation aerosol, solution op 162 Phenoterol + Ipratropium 1ml contains: 0,5mg phenoterol + 0,25mg ipratropium; nebulisation solution op 1744 1 Ibuprofen 60mg; suppositories pcs 1402 Ibuprofen 125mg; suppositories pcs 140 1 Fluticasone 0,05mg/g (0,005 %) ointment; op a 15g op 202 Fluticasone 0,5mg/g (0,5 %) cream; op a 15g op 34 Heparin 25000j.m./5ml; amp a 5ml amp 620 Esomeprazole 40mg; powder for solution for injection and infusion amp 6470 Isoniazide 100mg tbl 500 Mivacurium 2mg/ml; amp a 5ml amp 990 1 Phosphomycin powder for solution for infusion; 2g shoe. 1002 Phosphomycin powder for solution for infusion; 4g shoe. 100 Ciprofloxacin 3mg/ml; op a 5ml op 6 Glimepiride 2mg; tbl 420 Amoxicillin + clavulanic acid 5ml: contains 600mg amoxicillin and 42.9mg kw. Clavulanic acid; op a 100ml; suspension op 32 Oxymetasoline 0.1mg/g; op a 5ml; nasal drops, solution op 445 Etomidate sulphate 2mg/ml; amp a 10ml amp 450 1 Benzylpenicillin procaine 1 200 000 IU.; amp 3402 Clarytrhomycin 500mg; amp 18003 Doxycycline 100mg/5ml amp 404 Doxycycline 100mg cap 4505 Penicillinum crystallisatum 1 million IU amp 4006 Penicillinum crystallisatum 5 million IU.m amp 23507 Ampicillin + sulbactam 1g ampicillin + 500mg sulbactam; r-ru powder for injection and infusion amp 2208 Azithromycin 500mg; tbl 14889 Azithromycin 250mgl tbl 39010 Clarithromycin 500mg; tbl 271611 Hydrocortisone + Oxytetracycline 1g contains: 3.1mg hydrocortisone, 9.3mg oxytetracycline; aerosol op 1212 diazepam 5mg tbl 660013 diazepam 5mg/2ml (10mg/2ml); amp a 2ml; solution for injection amp 320014 clonazepam 2mg, tabl. tbl 30015 clonazepam 0.5mg, tbl 3016 clonazepam 1mg/ml; amp a 1ml amp 28017 Amoxicillin +clavulanic acid 625mg; tbl coated with tbl. 260418 Amoxicillin +clavulanic acid 875mg +125mg; Cable topped with table. 7420 1 Betaxolol 5mg/ml/ op a 5ml; eye drops op 42 Sodium cromoglicate 20mg/ml (2 %); 1 op a 10ml [2x 5ml]; eye drops op 43 Diclofenac 1mg/ml; op a 5ml; eye drops op 104 Dorzolamide 20mg/ml; op a 5ml; eye drops op 255 Dexamethasone + Neomycin + Polymyxin B 1ml contains: 1mg dexamethasone, 3500jm neomycin, 6000jm polymixin B; eye drops op 26 Norfloxacin 3mg/ml (0,3 %); op a 5ml; eye drops op 67 Carbomer 2mg/g; op a 10g; Eye gel op 208 Troxerutin 50mg/ml; op a 10ml; eye drops op 159 Proxymethacaine 5mg/ml; op a 15ml; eye drops op 51010 Trimsicine 3mg/g; op a 3,5g; eye ointment op 12011 Trimsicine 3mg/g; op a 5ml; eye drops op 200 1 Azathioprine 25mg; table tbl 2002 Cyclosporine 50mg; cap tbl 1003 Cyclosporine 100mg; cap tbl 100 1 Cholecalciferol 15000jm/ml; liquid 10ml op 2302 Glucose 200mg/ml (20 %); amp a 10ml; solution for injection amp 34503 Folic acid 15mg; tabl 40804 magnesium hydrogen aspirginate + potassium hydrogen aspirginate 1 tabl: 250 mg magnesium hydrogen aspirginate + 250mg potassium hydrogen aspirginate tabl 18005 Retinol 50 000 jm/ml; oral solution, drops; op a 10ml op 46 Tocopherol 100mg; cap tabl 6 1 Potassium chloride 391mg potassium ions/5ml; op a 150ml op 2852 Butamirate 1,5mg/ml; op a 200ml op 76 Esmolol 10mg/ml (100mg/10ml); amp a 10ml; solution for injection amp 10 1 Methylprednisolone Aceponate 0,1 % (15g); cream op 62 Methylprednisolone Aceponate 0,1 % (15g); ointment op 6 1 Insulin isophanic human N 100jm/ml; cartridge 3ml cartridge 802 Insulin neutralizes human R 100jm/ml; cartridge 3ml cartridge 7203 Insulin neutralis human + insulin isophanic human 30+70 100jm/ml; cartridge 3ml cartridge 20 Latanoprost 50ug/ml; op 7.5ml (3 x 2.5ml) op 20 1 Bisacodile 10mg; pcs. 48002 Activated carbon 200mg; cap tabl. 403 Dimethicone 1 drop contains 20mg dimethicone op 554 Composite 1ml contains: 139mg sodium dihydrogen phosphate, 32.3mg sodium hydrogen phosphate; op a 150ml; single-use rectal solution op 19205 Messalazine 10mg/ml (1g/100ml); op a 100ml; Porectal suspension op 86 Messalazine 250mg; suppositories 1507 Batadotrile 10mg; granule for oral suspension; op a 16 sachet 11208 Batadotrile 30mg; Oral use gran; op a 16 sachets sachet 6409 Pankreatine 10 000jm; cap 400 1 Diclofenac 50mg; suppositories pcs 602 Diclofenac 100mg; 10403 Ibuprofen 200mg; Tables tbl 78004 Paracetamol 250mg; Bollocks 1805 Paracetamol 500mg; Bollocks 260 1 Acyclovir 200mg; Tbl 46802 Acyclovir 400mg; 13803 Acyclovir 800mg; 3004 Amphotericin B 5mg/ml; amp a 20ml; infusion concentrate amp 405 Chloramphenicol 10mg/g (1 %); op a 5g; ointment op 156 Chloramphenicol 20mg/g (2 %); op a 5g; ointment op 2007 Clarithromycin 125mg/5ml; op a 60ml; suspension op 358 Clotrimazole 10mg/g (1 %); op a 20g; Cream op 3509 Dalbawanthin 500mg; end of r-ru powder for infusion amp 1010 Fluconazole 50mg; cap 408811 Fluconazole 100mg; cap 5612 Fluconazole 5mg/10ml; op a 150ml; syrup op 1013 Gancyclovir 500mg; r-ru powder for infusion amp 2014 Metronidazole 500mg; vaginal tbl 6015 Nystatin 100 000jm; tbl. vaginal tbl 22016 Nystatin 100 000jm;/ml (2,4mln/5g); op a 5,8g; pellets for oral and oral use op 13417 Nystatin 500 000jm; enteral tbl 9618 Sulfamethoxazole + trimethoprim 120mg; tbl 4019 Sulfamethoxazole + trimethoprim 200mg + 40mg/5ml; op a 100ml; Oral valve op 420 Sulfamethoxazole + trimethoprim 480mg; tbl 52021 Sulfamethoxazole + trimethoprim 960mg; tbl 128022 Sulfamethoxazole + trimethoprim (80mg+16mg)/ml; amp a 5ml; amp 4060 1 Amlodipine + Telmisartan 40mg telmisartan + 10mg amlodipine; tbl 2802 Amlodipine + Telmisartan 80mg telmisartan + 10mg amlodipine; tbl 2803 Amlodipine + Telmisartan 40mg telmisartan + 5mg amlodipine; tbl 2804 Amlodipine + Telmisartan telmisartan 80mg + 5mg amlodipine; tbl 2805 Bencyclan 100mgl tbl 2406 Bisoprolol 10mg; tbl 22807 Chlorthalidone 50mg; tbl 1608 Dabigatran etexilate 110mg; tbl 28809 Dabigatran etexilate 150mg; tbl 252010 Dioxin 0,25mg/ml; amp a 2ml amp 98511 Diltiazem 60mg; tbl 12012 Enalapril 20mg; tbl 24013 Epinephrine 1mg/ml (0,1 %); amp 650014 Ethamylate 125mg/ml (250mg/2ml); 12,5 %; amp a 2ml amp 1126015 Phenofibrate 215mg; tbl 6016 Nitroglycerin 10mg/10ml; amp a 10ml amp 69017 Nitroglycerin 0,4mg/dose; sublingual aerosol; op a 200 doses op 3418 Lacidypine 2mg; tbl 464819 Lysopril 5mg tbl 5620 Lysopril 10mg tbl 173621 Lysopril 20mg tbl 67222 Lysopril + Hydrochlorothiazide 10mg + 12.5mg tbl 12023 Losartan 50mg; tbl 2242424 Loperamide 2mg; tbl 360025 Metoprolol acetate 50mg; tbl 660026 Metoprolol acetate 1mg/ml; amp a 5ml amp 288027 Metoprolol tartrate 100mgl tbl 12028 Midodrin hydrochloride 2,5mg; tbl 20029 Norepinephrine 1mg/1ml; amp a 4ml amp 10030 Potassium chloride 391mg potassium ions; tbl 8292031 Propafenone hydrochloride 150mg; tbl 96032 Propranolol 1mg/ml; amp a 1ml amp 8033 Riwaroxaban 10mg; tbl 12034 Rivaroxaban 15mg; tbl 330035 Rivaroxaban 20mg; tbl 240036 Verapamyl chloride 40mg; tbl 88037 Verapamyl chloride 80mg; tbl 8038 Verapamyl chloride 240mg; tbl 12039 Verapamyl chloride 120mg; 8040 Verapamil hydrochloride 120mg; 16041 Vinpocetin 5mg; 200 Carvedilol 25 mg; 300 1 Dexketoprofen 25mg/ml (50mg/2ml); Amp a 2ml amp 12802 Dexketoprofen 25mg; Tbl 1803 Nebivolol 5mgl Tbl 8404 Metformina 500mgl Tbl 21605 Metformina 850mg Tbl 6006 Metformina 1000mg Tbl 2407 Pankreatine 10 000jm; Cap 7008 Pankreatine 25 000jm; Cap 10409 Torasemid 200mg; Tbl 64010 Torasemid 5mg; Tbl 192011 Calcium Sophenoprile 7.5mg tbl 5612 Calcium Sophenoprile 30mg tbl 952 1 Decmedetomidine 0.1mg/ml amp and 4ml amp 402 Decmedetomidine 0.1mg/ml; amp a 10ml amp 40 1 Aarbose 50mg, tbl 1202 Aarbose 100mg; tbl 1203 Bromocriptine 2,5mg; tbl 6604 Carbetocyin 0,1mg/ml amp a 1ml amp 1605 Clobetasol propionate 0,5mg;g (0,05 %); ointment; op a 25g op 2026 Dinoprost 5mg/ml; amp a 1ml amp 2807 Dydrogesterone 10mg; tbl 18008 Estradiol 1mg; tbl 569 Estradiol 2mg; tbl 5610 Glucagon 1mg glucagon; 1 vial + 1 amp; 1op=(1 vial + 1 amp-string) op 511 Levothyroxine 125mcg; tbl 10012 Levothyroxine 88mcg; TABLE 10013 Levothyroxine 25mcg; TABLE 440014 Linagliptin 5mg; TABLE 56018 Prednisone 1mg; TABLE 8019 Prednisone 20mg; TABLE 216020 Prednisone 25mg; powder and solvent for injection; 1op=(1 vial + 1 amplitude op 1021 Progesterone 50mg; TABLE 174022 Progesterone 50mg; sublingual tbl 450 1 Human Immunoglobulin normal (IVIG) 50mg/ml (2.5mg/50ml); flacon a 50ml flacon 702 Human Immunoglobulin normal (IVIG) 50mg/m; (1g/20ml); flacon a 20ml flacon 103 Human Immunoglobulin normal (IVIG) 50mg/m; (5g/100ml); flacon a 100ml flacon 44 Human immunoglobulin against hepatitis B virus 180jm/ml; amp a 1ml; solution for injection amp 30 1 Sugammadex 0,2g/2ml vial 1002 Urapidil 0,025g/5ml amp 12503 Urapidil 0,05g/10ml amp 160 Terlipressin 0,1mg/ml; amp a 8,5ml amp 320 1 Oseltamivir 30mg; hard cap 9902 Oseltamivir 45mg; hard cap 1203 Oseltamivir 75mg; hard cap 1260 1 Risperidone 1mg tbl 33602 Risperidone 2mg tbl 40 Ranitidine 150mg tbl 600 1 Insulinum humanum - short-acting obtained by recombination of DNA E.coli, (after subcutaneous injection start 30-40 min,peak of action between 1-3 h. Action time 5-7 h) 100jm/ml; 3ml insert 202 Insulinum humanum - prolonged action, obtained by recombination of E. coli DNA (after subcutaneous injection start of action after about 1 h, peak action between 2-8 h. Duration of action up to 20h) 100jm/ml; cartridge 3ml cartridge 203 Humanum Insulinum - mixed, two-phase, obtained by recombination of E.coli DNA, contains a combination of short-acting and prolonged action insulin in proportions 30/70 (after subcutaneous injection start of action after about 30 min, peak of action between 1-8 h. Action time 18-20 h.) 100jm/ml; cartridge 3ml cartridge 204 Insulinum lispro analog - fast-acting (after subcutaneous injection start of action after approx. 15 min, peak of action between 30-70 min. Action time 2-5 h.) 100jm/ml; 3ml cartridge 355 Insulinum lispro analog - mixed combination of short acting analog insulin and extended acting time 25/75, (after subcutaneous injection start of action after approx. 15 min, peak of action between 30-70 min.acting time approx. 15 h.) 100jm/ml; cartridge 3ml cartridge 206 Insulinum lispro analog - a mixed combination of short-acting analog insulin and extended duration of 50/50 (after subcutaneous injection start after approx. 15 min, peak of action between 30-70 min.Duration approx. 15 h.) 100jm/ml; 3ml cartridge 20 Midazolam *Psychotropic substance groups III-P, IV-P 7.5mgl tbl 8300 Alteplasma powder and solution; dose 10mg; 1op - 1 g. + dissolution. 10Ml amp 10 1 Ammlodipine 5mg, Cable 90902 Amoxicillin 250mg; Cable 1603 Amoxicillin 500mg tbl 15364 Ciprofloxacin 10mg/ml; Amp a 10ml amp 1826 Doxazosine 4mg; Cable 29408 Levofloxacin 250mg; 1209 Lefloxacin 500mg; 80011 Norfloxacin 400mg; 52012 Pantoprazole 20mg; 1456013 Pantoprazole 40mg; 459214 Ramipril 2.5mg; 432015 Ramipril 5mg; 443216 Roswastatin 10mg; tbl 50417 Roswastatin 15mg; tbl 11218 Roswastatin 20mg; tbl 11219 Sulfasalazin 500mg; tbl 80020 Sulfasalazin EN 500mg; tbl coated tbl 30021 Tiethylmerazine 6,5mg; tbl 5022 Tiethlperazine 6,5mg/ml amp and 1ml amp 5023 Hydrochlorothiazide + valsartan 80mg valsartan + 12,5mg hydrochlorothiazide tbl 5624 Venlafaxine 75mg; tbl 168 Methylthionine chloride 10mg/ml amp. 100 1 Ciprofloxacin in form of ciprofloxacin monohydrate 2mg/ml bottle 200ml 183502 Ciprofloxacin in form of ciprofloxacin monohydrate 2mg/ml bottle 100ml 2650 1 Amantadine 100 mg cap. 1002 Baclofen 10 mg tbl 4003 Topiramate 25 mg batch 1684 Topiramate 50 mg batch 1685 Roxithromycin 150mg batch 1006 Rifaximin 200 mg batch 59927 Paracetamol 0.5g/ 50ml bottle 51008 Formoterol 0.012 mg cap. including 2409 Acetylcysteinum inhaler 300mg/3ml amp. 54010 Roxithromycin 50mg tabl. 10011 Topiramate 100 mg tabl. 168 Gentamycin 0.08g/2ml amp 3050 1 Torasemide 10mg/2ml amp. 502 Aluminium acetotartrate 1 % 75g op. 3863 glycerine suppositories 2g each 2904 glycerine suppositories 1g each 40 Voriconazole 200mg tariff item 196 Milgamma N prep. fold, amp. 2 ml amp. 170 Immunoglobulinum humanum anti-D Immunoglobulinum humanum anti-D 300 mcg/2 ml, 1 amp. of teat. 610 Ertapenem 1 g vial 20 1 'Foodstuffs for special nutritional purposes': Liquid modified milk ready for administration to newborns and infants from birth, containing a total: - LCPUFA- galactose and fructooligosaccharides GOS/FOS 9:1 (0,8 g/100 ml) - with a minimum protein level of 1,3 g/100ml- with a maximum iron level of 0,6mg/100ml.- Maximum osmolarity of the mixture 285 mOsm/l; bottle volume 90ml' bottle 24002 Dietary foods for special medical purposes 'Dietary foods for special medical purposes .Hypoallergenic modified liquid infant formula ready for administration to newborns and infants of 90 ml, in which: - the source of protein is whey protein with a slight degree of hydrolysis - a patented, clinically tested composition of oligosaccharides (GOS/FOS), in the amount of 0.8g/100 ml)- containing DHA - 6.7 mg/100ml- containing nucleotides - with a maximum iron level of 0.53 mg/100ml.- with a minimum protein level of 1.5 g/100ml- Maximum mixture osmolarity 335 mOsm/l; bottle volume 90ml' bottle 62403 'Dietary foods for special medical purposes. Ready-to-eat modified milk (RTF) for infants with a small and very small birth weight of 70 ml, containing a total of: - a patented, clinically tested composition of oligosaccharides (GOS/FOS), 0.8g/100ml- containing long-chain polyunsaturated fatty acids (LCPUFA), medium-chain fatty acids (MCT) - containing nucleotides - with an iron level of 1.6 mg/100ml.- with a protein level of 2.6 g/100ml- Maximum mixture osmolarity 315 mOsm/l; bottle volume 70m' bottle 964 'Special dietary foods 'Special dietary foods Liquid modified milk ready to be administered to newborns and infants from birth, containing a total of:- a patented clinically tested composition of oligosaccharides (GOS/FOS), 0.8g/100ml- containing LCPUFA -DHA 10 mg/100ml- containing nucleotides - with a minimum protein level of 1.3 g/100ml- with a maximum iron level of 0.5 mg/100ml- Maximum mixture osmolarity 285 mOsm/l; bottle volume 90ml" bottle 96 1 Antazoline + Naphazoline 5 mg + 0.25 mg op. (gutt.oph. 2 x 5 ml) 602 Ciprofloxacin 2 mg/ ml op. (ear drops, 0.25 ml x 15 amp) 43 Budesonide 500 mcg/ ml, suspension for nebulisation, amp.2ml amp. 100 Linezolide 600mg tabl.powl. 20 1 Clorazepate dipotassium; psychotropic substance 10 mg tabletop 3602 Clorazepate dipotassium; psychotropic substance 5 mg tabletop 1500 Human albumin 200 mg/ml, vial 10 ml vial 120 1 Ciprofloxacinum 250mg tabletopl. 1202 Ciprofloxacinum 500mg tabletopl. 5400 1 Cefotaxime 1 g vial. 55502 Cefotaxime 2 g vial. 3700 1 Ampicillin 1 g vial 84702 Ampicillin 0.5 g vial 6070 Bewacyzumab 25mg/ml, vial 4 ml vial 24 Fondaparinux 2.5 mg/ 0.5 ml amp-intake 500 Clindamycin 300mg tabl./cap. 2080 Methotrexate 2.5 mg, tablets tabl 300 Cefazolinum 1.0g vial. 9600 1 Amikacin 0.25g/2ml, r-r for injection and infusion, pcs. 7502 Amikacin 1.0g/4ml, r-r for injection and infusion, pcs. 150 Clomipramine 75mg, pre-release tablets 150 Betaxolol 20mg, tablets 150 1 Kandesartan 8 mg, tablets, tablets 1402 Kandesartan 16 mg, tablets, tablets 140 1 liquid for skin application; 100 g contains: 96g field fairy tinctures, 4g 80% acetic acid, 100 ml pack op. 2002 medical shampoo, contains permethrin 10 mg/ml, 50 ml pack op. 200 Iron in syrup 10mg Fe III/ml, 100 ml pack op. 30 1 Cilazapril coated tablets, 2.5 mg tabl. 1402 Cilazaprylic film-coated tablets, 5 mg display case 140 1 Lerkanidipine hydrochloride film-coated tablets, 10 mg display case 1402 Lerkanidipine hydrochloride film-coated tablets, 20 mg display case 140 Methoxalene 10 mg, soft caps. 15000 Metamizol solution for injection, 500mg/ml, amp. 2 ml; from 3 months old amp. 9600 Hypoallergenic infant modified milk with OPTOPRO H.A. protein content not higher than 1.3g/100ml bottle 11648 Alpha-Lipoic acid 600 mg, soft capsules/tablets coated caps./table 150 1 Olanzapinum 5 mg tbl. Coated with Table 2242 Olanzapinum 10 mg tbl. Coated Table 224 Protaminum sulfuricum Solution for injection, 0.01g/ml, amp. 5ml amp. 10 1 Trazodone hydrochloride prolonged-release tablet, 75 mg tablet showing 1502 Trazodone hydrochloride prolonged-release tablet, 150 mg tablet showing 100 Thiamine hydrochloride solution for injection, 50g/ml, amp. 960 Electrolyte level complement solution Solution for infusion, 1000ml bag composition; anhydrous glucose 50 g, sodium chloride 1 g, sodium trihydrate 3,13 g, potassium chloride 1,5 g, hexagonal magnesium chloride 0,3 g pcs 500 1 medicinal product for parenteral nutrition Three-chamber bag for parenteral nutrition for central administration containing electrolytes, amino acids, glucose and a fatty emulsion (80 % olive oil and 20 % soybean oil); nitrogen 7,8g amino acid content 49,4g total energy 620kcal volume 650ml bag 4802 parenteral nutrition medicinal product Three-chamber bag for parenteral nutrition for central administration containing electrolytes, amino acids, glucose and fat emulsion (80 % olive oil and 20 % soya bean oil); nitrogen 12 amino acid content 75,9g total energy 950kcal volume 1000ml bag 4803 parenteral nutrition medicinal product Three-chamber parenteral nutrition bag for central administration containing electrolytes, amino acids, glucose and fat emulsion (80 % olive oil and 20 % soya bean oil); nitrogen 18g amino acid content 113,9g total energy 1420kcal volume 1500ml bag 4804 solution Pediatric 10 % amino acid solution without electrolytes, with glutamic acid content, for use in premature infants and children, osmolarity 780 mOsm/l, taurine 0,6g/1000ml, for intravenous infusions, bottle 100 ml bottle 300 Infant infant's infant's milk Infant's birthday starter milk 59ml with DHA and MFGM pcs 960 Bottle nipple, Enfamil Standard-flow pcs 960 Sodium Enoxaparin 300mg/3ml; Solution for injection + syringes + mini spike amp 8500 1 bag for parenteral nutrition three-chamber bag containing amino acid solution with taurine, electrolytes, glucose, fat emulsion containing soya oil, medium chain triglycerides, olive oil and fish oil rich in omega 3 fatty acids. Normal sack. They do not contain glutamic acid. Volume 850ml, extra-grain energy 530kcal, 3,41g nitrogen, amino acids 21,3g pcs. 1002 parenteral nutrition bag Three chamber bag containing solution of amino acids with taurine, electrolytes, glucose, fat emulsion containing soybean oil, medium chain triglycerides, olive oil and fish oil rich in omega 3 fatty acids. Normal sack. They do not contain glutamic acid. Volume 1400ml, extra-grain energy 872kcal, nitrogen 5,6g, amino acids 35g pcs 1003 parenteral feeding bag three-chamber bag containing solution of amino acids with taurine, electrolytes, glucose, fat emulsion containing soybean oil, medium chain triglycerides, olive oil and fish oil rich in omega 3 fatty acids. Normal sack. They do not contain glutamic acid. Volume 1950ml, 1215kcal extra-grain energy, 7,81g nitrogen, 62,6g amino acids 100 Amphotericin B 50mg; vial 20 1 Acenocumarol 4mg tabl. 4802 Magnesium sulfuricum 20 %;2,0g/10ml amp. 90003 Quetiapine 25 mg, Tablet. Coated pcs. 150604 Piracetam 20 %;12g/60ml flacon 4005 Piracetam 800mg tabl.plated 2406 Piracetam 1200mg tabl.powl. 4807 Budesonide 125mcg/ml suspension for nebulization;amp 2ml 8008 Pentoxyfillinum 300mg/15ml amp. 2008 Pentoxyfillinum 400mg tabl.o prel.release. 4809 Tramadol hydrochloride 50mg cap. 2400010 Tramadol Hydrochloride 0.1g/ml, oral drops, op= 10 ml op. 1011 Tramadol Hydrochloride 100mg tabl.o prev.l. 18012 Solcoseryl 42.5 mg/ml amp 2 ml 10013 Cefoperazonum-sulbactamum 2.0 g dsp.r-ru powder for inj.i.v. I inf.;fiol. 2014 Ascorbic acid 100mg/ml drops 30 ml 815 Bromfenac eye drops, 0.9 mg/ml op. 80 1 dietary supplement Wound treatment aid diet, nutritionally incomplete, powder, high energy, for oral supply. Containing an increased amount of L-arginine, collagen hydrolysate, zinc in the form of Albion chelate, and high doses of vitamins A and C. Gluten-free product. Clinically lactose free. A 12.5 g sachet, 14 sachet packs. op. 1002 dietary preparation "Foods for special medical purposes. Product intended for dietary management. Contains a composition of essential nutrients - proteins, carbohydrates, fats, vitamins, micro- and macroelements, as well as omega-3 acids, L-arginine and beta-1.3/1.6 glucan. It can be both a complete replacement of the diet and a supplement to it. A large economic package of the bag type open and close. op a 780g" op 1003 nutritional preparation Nutritionally complete, powdered, high-energy, high-protein, non-restrictive diet, for oral supply. Containing three protein sources - whey protein concentrate, calcium caseinate and whey protein isolate. The carbohydrate source is corn maltodextrin. The sources of fats are vegetable oils LCT/MCT. Gluten-free product. Clinically lactose free. 70g sachet, 6 sachets per package. Osmolarity 290 mOsm/l. op. 100
- Opportunity closing date
- 22 July 2020
- Value of contract
- to be confirmed
About the buyer
- Address
- Szpital Specjalistyczny im. Stefana Żeromskiego SPZOZ w Krakowie os. Na Skarpie 66 Kraków 31-913 Poland
- Contact
- zpubl@zeromski-szpital.pl
The deadline to apply for this opportunity has passed.
Visit the
opportunities page
to find another.